Symbiox Investment & Trading Co Ltd (SYMBIOX) — shareholding pattern, promoter holding, financials and share price
About Symbiox Investment & Trading Co Ltd (SYMBIOX)
Symbiox Investment & Trading Co Ltd operates in the Other Financial Services industry, within the Financial Services sector. It trades on the NSE as SYMBIOX and on the BSE under scrip code 539278. Its ISIN is INE653R01012.
Incorporated in 1979, Symbiox Investment & Trading Company Ltd is mainly into Trading in textile goods, and Loans & Investments. [1]
Symbiox Investment & Trading Company Limited is primarily engaged in trading in investments and textiles, offering a diverse variety of sarees.
The company is working towards becoming a comprehensive provider for retailers by expanding its textile offerings.
Listed peers in Other Financial Services: Gujarat Credit Corporation Ltd, Delta Industrial Resources Ltd, PS IT Infrastructure & Services Ltd, Aryan Share & Stock Brokers Ltd, Munoth Communication Ltd, Kanungo Financiers Ltd.
Valuation & Returns
10 Jul 2026At ₹1.61 a share on 10 Jul 2026, Symbiox Investment & Trading Co Ltd (SYMBIOX) was valued at a price-to-earnings ratio of 33.58x against an industry P/E of 19.5x and a price-to-book of 0.16x on a book value of ₹10.14 per share as of Mar 2025. Solomo computes return on equity of 0.47% and return on capital employed of 0.65% from filed results. Earnings ratios use standalone results for the twelve months Jun 2025 to Mar 2026.
- P/E
- 33.58x
- Industry P/E
- 19.5x
- P/B
- 0.16x
- EPS (TTM)
- ₹0.05
- Book value / share
- ₹10.14
- ROE
- 0.47%
- ROCE
- 0.65%
- ROA
- 0.47%
- Debt / equity
- 0x
- Dividend yield
- 0%
- EBITDA margin
- 13.04%
- 52-week range
- ₹1.36 – ₹3.7
Ratios are computed from filed results and the last recorded price. Not investment advice.
Financial Performance
Mar 2026In the year ended Mar 2026, Symbiox Investment & Trading Co Ltd (SYMBIOX) reported revenue of ₹1.6 crore, net profit of ₹0.15 crore and earnings per share of ₹0.05. That compares with revenue of ₹2.77 crore and net profit of ₹0.19 crore in Mar 2025. Figures are standalone, as filed with the exchanges.
In the quarter ended Mar 2015, revenue was ₹0.9 crore and net profit ₹0.03 crore (consolidated).
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue (₹ cr) | 1.83 | 4 | 4.13 | 2.77 | 1.6 |
| Net profit (₹ cr) | 0.14 | 0.16 | 0.21 | 0.19 | 0.15 |
| EPS (₹) | 0.04 | 0.05 | 0.07 | 0.06 | 0.05 |
| Measure | 10Y | 5Y | 3Y | 1Y |
|---|---|---|---|---|
| Sales growth | 17.83% | 21.63% | 14.73% | -32.93% |
| Profit growth | 18.84% | 51.86% | 11.38% | -9.52% |
| Stock price CAGR | -25% | 0% | -22% | -45% |
Ownership Summary
Jun 2026As of Jun 2026, promoters hold 3.33% of Symbiox Investment & Trading Co Ltd (SYMBIOX) (unchanged from the previous quarter). Market capitalisation was ₹5 crore on 10 Jul 2026. Shareholding is filed quarterly with BSE and NSE; Solomo carries every filing back to Jun 2015.
Largest disclosed public shareholders in Jun 2026: SUSHANTA NASKAR 2.07%, MAHESH KHANDELWAL 1.94%, VINOD CHANDRA BHATT 1.92%, FRANKLIN LEASING AND FINANCE LIMITED 1.72%, BHARATBHAI RAVATBHAI KHACHAR 1.53%, YUGAM ANURAG RAWAT 1.29%. Only stakes above the 1% disclosure threshold are named in filings.
| Quarter | Promoter | Pledged | FII | DII | Public |
|---|---|---|---|---|---|
| Jun 2026 | 3.33% | - | - | - | 96.67% |
| Mar 2026 | 3.33% | - | - | - | 96.67% |
| Dec 2025 | 3.33% | - | - | - | 96.67% |
| Sep 2025 | 3.33% | - | - | - | 96.67% |
| Jun 2025 | 3.33% | - | - | - | 96.67% |
| Mar 2025 | 3.33% | - | - | - | 96.67% |
| Dec 2024 | 3.33% | - | - | - | 96.67% |
| Sep 2024 | 3.33% | - | - | - | 96.67% |